Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2008 by Kansas City Veteran Affairs Medical Center.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Kansas City Veteran Affairs Medical Center
ClinicalTrials.gov Identifier:
NCT00728520
First received: July 31, 2008
Last updated: August 5, 2008
Last verified: August 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)